Lipid Screening Study
ConditionLipoprotein (a)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Central Florida
About this trial
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 years or older
Receiving care at UCF Health primary care clinic
Able to understand and provide informed consent and HIPAA authorization
Disqualifiers
Patient self discloses any medical condition that would make venipuncture unsafe
Pregnant women
Trial population
As any adult patient can be enrolled, no pre-screening will be done. UCFH only sees adult patients.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Venipuncture
Other interventionThe study procedures include a single venipuncture (10 mL) performed for research purposes to obtain blood samples for laboratory analysis of lipoprotein(a), apolipoprotein B, and a lipid panel with reflex to direct Low-Density Lipoprotein (LDL) cholesterol measurement. The lipid panel includes total cholesterol, triglycerides, High-Density Lipoprotein (HDL) cholesterol, and calculated non-HDL cholesterol and cholesterol/HDL ratio. If triglyceride levels exceed the laboratory threshold for accurate calculation of LDL cholesterol, a direct LDL cholesterol assay will be performed per standard laboratory protocol. In addition, the study includes abstraction of demographic and clinical information from the electronic medical record (EMR), including age, sex, BMI, comorbid conditions, and cardiovascular history. All laboratory analyses will be performed using standard clinical laboratory assays. No investigational drugs or medical devices are being used in this study.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Lipoprotein(a) prevalence in Adults
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov